Form 8-K - Current report:
SEC Accession No. 0001104659-22-010300
Filing Date
2022-02-01
Accepted
2022-02-01 16:03:17
Documents
12
Period of Report
2022-02-01
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm224824d1_8k.htm   iXBRL 8-K 27795
  Complete submission text file 0001104659-22-010300.txt   199544

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gild-20220201.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20220201_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20220201_pre.xml EX-101.PRE 22591
6 EXTRACTED XBRL INSTANCE DOCUMENT tm224824d1_8k_htm.xml XML 3488
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 22578869
SIC: 2836 Biological Products, (No Diagnostic Substances)